长期双膦酸盐治疗导致的非典型骨折。
Atypical fractures on long term bisphosphonates therapy.
作者信息
Hussein W, Cunningham C, Logan H, Fallon C, Murphy S
机构信息
Midland Regional Hospital, Mullingar, Co Westmeath.
出版信息
Ir Med J. 2011 Nov-Dec;104(10):308, 310.
PMID:22256444
Abstract
Bisphosphonates reduce fractures risk in patients with osteoporosis. A new pattern of fractures is now being noted in patients on prolonged bisphosphonate therapy. We report a case of an atypical femoral fracture with preceding pain and highlight the characteristics of these fractures.
摘要
双膦酸盐可降低骨质疏松症患者的骨折风险。目前，长期接受双膦酸盐治疗的患者中出现了一种新的骨折模式。我们报告一例伴有先前疼痛的非典型股骨骨折病例，并强调这些骨折的特征。
相似文献
1
Atypical fractures on long term bisphosphonates therapy.
Ir Med J. 2011 Nov-Dec;104(10):308, 310.
2
[New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].
Clin Calcium. 2009 Jan;19(1):38-43.
3
[Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].
Clin Calcium. 2011 Oct;21(10):1543-6.
4
Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases.
J Med Assoc Thai. 2011 Dec;94 Suppl 7:S214-20.
5
Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.
Geriatrics. 2009 Jan;64(1):18-23.
6
[Osteoporotic fracture in menopausal women: alendronate reduces the risk].
Rev Med Suisse. 2008 Dec 10;4(183):2703.
7
Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.
Menopause. 2012 Dec;19(12):1360-3. doi: 10.1097/gme.0b013e318260143d.
8
A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
J Bone Joint Surg Br. 2012 Jul;94(7):994-7. doi: 10.1302/0301-620X.94B7.28778.
9
[Alendronate for treatment of osteoporoses].
Nihon Rinsho. 2009 May;67(5):943-7.
10
Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
J Clin Endocrinol Metab. 2013 Apr;98(4):E723-6. doi: 10.1210/jc.2012-4144. Epub 2013 Mar 7.
Zotero 插件